TargetMol

O-1602

Product Code:
 
TAR-T23097
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T23097-1mg1mg£103.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T23097-5mg5mg£148.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T23097-1mL1 mL * 10 mM (in DMSO)£156.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T23097-10mg10mg£195.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T23097-25mg25mg£322.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T23097-50mg50mg£466.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T23097-100mg100mg£647.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
GPR55 cannabinoid receptor agonist
CAS:
317321-41-8
Formula:
C17H22O2
Molecular Weight:
258.361
Pathway:
GPCR/G Protein|Metabolism|Membrane transporter/Ion channel
Purity:
0.98
SMILES:
CC(=C)[C@@H]1CCC(C)=C[C@H]1c1c(C)cc(O)cc1O
Target:
Calcium Channel|Cannabinoid Receptor

References

1. Baffert F, R?gnier C H, De Pover A, et al.? Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805[J]. Molecular cancer therapeutics, 2010, 9(7): 1945-1955. 2. Bole-Feysot C, Goffin V, Edery M, et al.? Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice[J]. Endocrine reviews, 1998, 19(3): 225-268. 3. Rubert J, Qian Z, Andraos R, et al.? Bim and Mcl-1 exert key roles in regulating JAK2 V617F cell survival[J]. BMC cancer, 2011, 11(1): 1.